“The Whole World in One Fractal” — A TRYP Expo Recap

Last week, a big States of Mind team made the trip to Berlin for TRYP Expo 2026. Held May 15-17 at the iconic Funkhaus Berlin, TRYP is Europe’s largest gathering dedicated to the psychedelic industry, blending science, wellness, and human energy. Over three days, this expo brought together researchers, clinicians, practitioners, artists, and curious minds from across the continent — with more than 80 speakers, 150+ exhibitors, and countless conversations.

Our team took the stage with a keynote From Fringe to Framework: Building the Infrastructure of Psychedelic Practice. The core idea is simple but vital: as psychedelic-assisted therapy becomes more accessible across Europe, the field still lacks the independent verification, shared standards, and accountability — the real infrastructure, in short, to support it safely.

Good intentions are not a safety standard.
The quality of your psychedelic experience should never be a matter of luck.

But what does the rest of the community think — and what future are they here to build? To get to know the TRYP community better, we went around the space and asked guests three questions:

What brought you into psychedelics?
What unites you with the people here?
What do you wish to see in the future of the psychedelic industry?

Curious about the answers? So were we — and here’s what we heard.

Daniel Brunner, alternative medicine practitioner, Bodawerk

Daniel on Instagram and LinkedIn

Farhad, psychedelic bodywork practitioner

Farhad on Instagram

Good Mood Food Team

Good Mood Food Instagram

Laurin Angermeier, neuroscientist, co-founder of ‘inLighten Berlin’

Laurin on LinkedIn

Max de Rosnay, directory & certification lead, Pink Elephant

Max on LinkedIn

And some other wonderful guests

This article is intended for informational and educational purposes only and does not constitute medical or legal advice. Substances such as ketamine, psilocybin, and other psychedelics are classified as controlled substances in many jurisdictions, and their legal status, clinical approval, and permitted use vary significantly by country and region. Psychedelic-assisted interventions are not considered first-line treatments for most psychiatric conditions and remain subject to ongoing clinical research and regulatory oversight. Any consideration of treatment involving these substances should occur under the supervision of a licensed healthcare professional and in accordance with applicable laws and medical guidelines. Do not initiate, discontinue, or modify any treatment without consulting a qualified clinician.

Anna Lindner

Anna is a journalist and editor focused on social media, tech, progressive wellness, and mental health. Her work explores how new scientific research and discoveries shape our understanding of mental health and different mental states worldwide.